Skip to product information
1 of 1

Boehringer Ingelheim

Alpha-7/MB-1

Alpha-7/MB-1

Regular price $19.60 USD
Regular price Sale price $19.60 USD
Sale Sold out
Size

Available in 10 dose and 50 dose.

Safe to Use in Pregnant Animals.

One dose 7-way blackleg plus pinkeye. Recommended for the vaccination of healthy, susceptible cattle as an aid in the reduction of diseases caused by Clostrdium chauvoei, septicum, novyi, sordellii, perfringens Types C&D and Moraxella bovis.

Dosage: Single 2 mL dose SQ to cattle 2 months of age or older, prior to the onset of pinkeye season. Calves vaccinated under 3 months of age should be revaccinated at weaning or at 4-6 months of age. A 2 mL booster dose is recommended annually. 60-day slaughter withhold.

Manufacturer and/or Label Information

BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
3239 SATELLITE BLVD., BLDG 500, DULUTH, GA, 30096
Telephone: 800-325-9167
Customer Service: 800-243-0127
Fax: 816-236-2717
Website: www.boehringer-ingelheim.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.
ALPHA-7/MB-1®

Boehringer Ingelheim Animal Health

Clostridium Chauvoei-Septicum-Novyi-Sordellii-Perfringens Types C & D-Moraxella Bovis Bacterin-Toxoid

BEEF & DAIRY CATTLE

Indications: This product has been shown to be effective for the vaccination of healthy cattle against Clostridium chauvoei, Cl. septicum, Cl. novyi, Cl. sordellii, Cl. perfringens types C and D, and against pinkeye (infectious bovine keratoconjunctivitis) due to Moraxella bovis. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity against M. bovis is at least 4 months. The duration for the remaining organisms has not been determined. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Although Cl. perfringens type B is not a significant problem in the U.S.A., immunity may be provided against the beta and epsilon toxins elaborated by Cl. Perfringens type B. This immunity is derived from the combination of types C (beta) and type D (epsilon) fractions.

Composition: Prepared from chemically inactivated cultures of Cl. chauvoei, Cl. septicum, Cl. novyi, Cl. sordellii, Cl. perfringens types C and D and M. bovis with the special DD-2 adjuvant system to maximize immune response. Gentamicin added as a preservative.

Directions and dosage: Mix well before use. Using aseptic technique, inject a single 2 mL dose subcutaneously prior to the onset of pinkeye season. The presence of maternal antibody is known to interfere with the development of active immunity in cattle and additional boosters will be required in most young animals. Contact your veterinarian or the manufacturer for information on revaccination frequency.

Precautions: Store out of direct sunlight at 35-46°F (2-8°C). Do not freeze. Do not mix with other products. Use entire contents when first opened. Do not vaccinate within 60 days before slaughter. The use of a biological product in lactating dairy cattle can cause reduced milk production. Injection site swelling will often occur that may persist. In case of anaphylactoid reaction, administer epinephrine. This product has not been tested in pregnant animals. In case of human exposure, contact a physician immediately.

Boehringer Ingelheim Animal Health USA Inc., St. Joseph, MO 64506

Phone: 1 (888) 637-4251

VLN/PCN 124/7425.01

Single dose 10 Doses/20 mL

115301-07

Single dose 50 Doses/100 mL

115302-06

CPN: 1028151.2



COLORADO SERUM COMPANY4950 YORK STREET, P.O. BOX 16428, DENVER, CO, 80216-0428Telephone: 303-295-7527Order Desk: 800-525-2065Fax: 303-295-1923Website: www.colorado-serum.comEmail: colorado-serum@colorado-serum.comTHIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

TETANUS TOXOID-CONCENTRATED

Colorado Serum

Adjuvanted

GENERAL INFORMATION: This product has been shown to be effective for the vaccination of healthy horses, cattle, sheep, goats, and swine against tetanus. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity is unknown. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Safety in pregnant animals is unknown.

Tetanus Toxoid is prepared by detoxifying tetanus toxin in such a manner as to allow the antigenic properties to remain intact. Product is purified, concentrated and adjuvanted to provide a low dose effective immunizing agent.

Each serial is tested for purity, safety, and potency in accordance with USDA requirements.

Tetanus is caused by a neurotoxin produced by growth of Clostridium tetani, an anaerobic (lives without air) micro-organism, in necrotic tissue. Affected animals become stiff, have difficulty swallowing, and have an increased pulse rate. Breathing is labored. Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw.

Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw. Thus, the term “lockjaw” is often used. Legs and tail are often stiff with abdominal muscles contracted. Tetanus stricken animals may be unusually sensitive to light and heat. Temperature of the animal generally remains normal, elevating only shortly before death.

Protective antibody levels usually occur about two weeks after the second injection of the primary immunization series. In contrast, administration of Tetanus Antitoxin is recommended for immediate, emergency, passive treatment of exposed animals with unknown vaccination history or with signs of tetanus infection.

DIRECTIONS: Do not vaccinate within 21 days before slaughter. Store at 2-8° C. Do not freeze. Do not mix with other products. Shake well before use. Use entire contents when first opened.

PRECAUTIONS: A transitory local reaction may occur at injection site. Anaphylactoid reaction may occur following administration of products of this nature. If noted, administer adrenalin or equivalent. In case of human exposure, consult a physician.

DOSAGE & ADMINISTRATION: For primary immunization, two doses should be administered subcutaneously or intramuscularly approximately 30 days apart. Use intramuscularly for horses as local reactions are more likely to occur if injected subcutaneously.

Horses: 1 ml IM

Cattle: 1 ml SC or IM

Sheep, Goats, Swine: 0.5 ml SC or IM

Historically, annual single dose revaccination has been recommended. Contact veterinarian for advice.

OTHER INFORMATION: Contains thimerosal and formalin as preservatives. Tetanus Toxoid Concentrate is available in single dose size packaged 10 vials to the carton, and in 10 dose vials.

THE PEAK OF QUALITY SINCE 1923

VLN: 188 / PCN: 8601.00

COLORADO SERUM COMPANY, 4950 York Street, Denver, Colorado 80216

303-295-752

www.colorado-serum.com

Contact us for information on other Colorado Serum Company products. Fine Veterinary Products since 1923.

FOR VETERINARY USE ONLY

 

 

Order #

10 - 1 ml vials

10 - 1 dose vials

11411

10 ml

10 doses

11415

CPN: 1101033.3

Dimensions

Care information

View full details